Oncology News

Contrast-enhanced MRI better detected hepatocellular carcinomas than diffusion-weighted MRI, but the two in combination slightly increased detection rates in a recent study.

Factors including cirrhosis, chronic HBV/HCV infection, obesity, diabetes and alcohol use were linked to an increased risk for intrahepatic cholangiocarcinoma in a recent study.

Consumption of fish rich in n-3 polyunsaturated fatty acids can be protective against hepatocellular carcinoma, even in patients with HBV or HCV infection, according to recent study results.

Patients with hepatocellular carcinoma and a background of nonalcoholic steatohepatitis may be more likely to survive after curative treatment than patients with carcinomas arising from hepatitis C and/or alcoholic liver disease, according to recent data.

SAN DIEGO — Patients who are infected with hepatitis C and hepatitis B are at significantly increased risks for cirrhosis, hepatocellular carcinomas and death, according to data presented at the 2012 Digestive Disease Week Annual Meeting.

The presence of extrahepatic primary malignancies does not affect a patient’s hepatocellular carcinoma survival rate and should not preclude such patients from receiving curative therapies, according to recent results.

A study of patients with hepatocellular carcinoma showed significant increases in hospital admissions and procedure volume rates during the last decade, according to data presented Friday at the International Liver Congress in Barcelona, Spain.

Childhood obesity correlated with an increased risk for adult liver cancer, according to new data presented Saturday at the International Liver Congress in Barcelona, Spain.

Hepatoma-derived growth factor-related protein-3 appeared to be essential for hepatocellular carcinoma pathogenesis, according to recent data, making it a potential molecular target for new drugs.

Personalized hepatitis C therapy with fewer side effects and improved success rates could soon become a reality, according to a systematic review of recent clinical trials.